您当前的位置:
Lycorine chloride. (Synonyms: 石蒜碱)
目录号: PC13385 纯度: ≥98%
CAS No. :2188-68-3
商品编号 规格 价格 会员价 是否有货 数量
PC13385-20mg 20mg ¥490.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
Lycorine chloride.
中文别名
盐酸石蒜碱;6-碘苯并二氢吡喃-4-醇;Lycorine chloride 盐酸石蒜碱 标准品;石蒜碱;盐酸石蒜碱(标准品);盐酸石蒜碱,Lycorine Hydrochloride,植物提取物,标准品,对照品;盐酸石蒜碱\石蒜碱盐酸盐、水仙碱、异鼠李素-3-Β-D-芸香糖甙;盐酸石蒜碱Lycorine chloride;葫芦巴碱盐酸盐;石蕊碱;盐酸葫芦巴碱;盐酸石蒜碱(石蒜碱盐酸盐,水仙碱);盐酸石蒜碱,Lycorine chloride,分析标准品;盐酸石蒜碱,Lycorine hydrochloride,对照品,标准品,中草药;盐酸石蒜碱,医药级,纯度:>99%
英文名称
(1R,17S,18R,19S)-5,7-Dioxa-12-azapentacyclo[10.6.1.02,10.04,8.015,19]nonadeca-2,4(8),9,15-tetraene-17,18-diol
英文别名
Lycorine hydrochloride;Lycorine chloride;Lycorine (hydrochloride);Lycorine Hydrochlori;galanthidine,hydrochloride;Licorin hydrochloride;(1R,17S,18R,19S)-5,7-Dioxa-12-azapentacyclo[10.6.1.02,10.04,8.015,19]nonadeca-2,4(8),9,15-tetraene-1
Cas No.
2188-68-3
分子式
C16H17NO4
分子量
287.31
包装储存

4°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

生物活性

Lycorine hydrochloride is the main active ingredient of the herbal medicine derived from Lycoris radiata (L’Her.) Herb. and is also a melanoma vasculogenic inhibitor and has anti-tumor activity. Lycorine hydrochloride effectively inhibits mitotic proliferation of Hey1B cells (IC50 of 1.2 μM).

性状

Solid

IC50 & Target[1][2]

IC50: 1.2 μM (Hey1B cells )

体外研究(In Vitro)

Lycorine hydrochloride (0-25 μM; 48 hours; C8161 cells) treatment markedly suppresses the expression of vascular endothelial (VE)-cadherin in a dose-dependent manner and also slightly diminishes the expression of Sema4D in C8161 cells. However, the expression of the other six genes is not affected.
Lycorine hydrochloride (0-25 μM; 48 hours; C8161 cells) treatment markedly reduces VE-cadherin protein levels in C8161 cells in a dose-dependent fashion.

Medlife has not independently confirmed the accuracy of these methods. They are for reference only.

RT-PCR

Cell Line: C8161 cells
Concentration: 0 μM, 1.56 μM, 3.13 μM, 6.25 μM, 12.5 μM, 25 μM
Incubation Time: 48 hours
Result: Markedly suppressed the expression of VE-cadherin in a dose-dependent manner and also slightly diminished the expression of Sema4D in C8161 cells.

Western Blot Analysis

Cell Line: C8161 cells
Concentration: 0 μM, 1.56 μM, 3.13 μM, 6.25 μM, 12.5 μM, 25 μM
Incubation Time: 48 hours
Result: Markedly reduced VE-cadherin protein levels in C8161 cells in a dose-dependent fashion.
体内研究(In Vivo)

Lycorine hydrochloride (0-15 μg; subcutaneous injection; for 14 days; BALB/C nude mice) treatment has an inhibitory effect on melanoma cell-mediated tumor vasculogenic mimicry.

Medlife has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: 6- to 8-week-old BALB/C nude mice
Dosage: 0 μg, 7.5 μg, 15 μg
Administration: Subcutaneous injection; for 14 days
Result: Showed an inhibitory effect on melanoma cell-mediated tumor vasculogenic mimicry.
运输条件

Room temperature or refrigerated transportation.

储存方式

4°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

结构分类
来源
参考文献
溶解度数据
体外研究: 

DMSO : 25 mg/mL (77.22 mM; Need ultrasonic)

H2O : 16.67 mg/mL (51.49 mM; Need ultrasonic)

配制储备溶液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 3.0886 mL 15.4431 mL 30.8861 mL
5 mM 0.6177 mL 3.0886 mL 6.1772 mL
10 mM 0.3089 mL 1.5443 mL 3.0886 mL
*

产品不同,其溶解度不同。建议根据产品选择合适的溶剂配制储备溶液;配成溶液后,建议分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)。-80°C 储存时,建议在 6 个月内使用,-20°C 储存时,建议在 1 个月内使用。

体内研究:

建议根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都建议先按照 体外研究 方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    建议依照次序添加每种溶剂: 10% DMSO    40% PEG300    5% Tween-80    45% saline

    Solubility: ≥ 2.08 mg/mL (6.42 mM); Clear solution

    此方案可获得 ≥ 2.08 mg/mL (6.42 mM,饱和度未知) 的澄清溶液。

    以 1 mL 工作液为例,取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀;向上述体系中加入50 μL Tween-80,混合均匀;然后继续加入 450 μL生理盐水定容至 1 mL。

    将 0.9 g 氯化钠,完全溶解于 100 mL ddH?O 中,得到澄清透明的生理盐水溶液
  • 2.

    建议依照次序添加每种溶剂: 10% DMSO    90% (20% SBE-β-CD in saline)

    Solubility: ≥ 2.08 mg/mL (6.42 mM); Clear solution

    此方案可获得 ≥ 2.08 mg/mL (6.42 mM,饱和度未知) 的澄清溶液。

    以 1 mL 工作液为例,取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 900 μL 20% 的 SBE-β-CD 生理盐水水溶液中,混合均匀。

    将 2 g 磺丁基醚 β-环糊精加入 5 mL 生理盐水中,再用生理盐水定容至 10 mL,完全溶解,澄清透明
  • 3.

    建议依照次序添加每种溶剂: 10% DMSO    90% corn oil

    Solubility: ≥ 2.08 mg/mL (6.42 mM); Clear solution

    此方案可获得 ≥ 2.08 mg/mL (6.42 mM,饱和度未知) 的澄清溶液,此方案不适用于实验周期在半个月以上的实验。

    以 1 mL 工作液为例,取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中,混合均匀。

*
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2